Similar associations of total adiponectin and high molecular weight adiponectin with cardio-metabolic risk factors in a population of overweight and obese postmenopausal women: A MONET Study

Hormone and Metabolic Research

Volumn 42, Issue 8, 2010, Pages 590-594

  Elisha, B ^a,b,c   Ziai, S ^a,b,c   Karelis, A D ^d   Rakel, A ^e   Coderre, L ^b,f   Imbeault, P ^g   Rabasa Lhoret, R ^a,b,c,e  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c Montreal Diabetes Research Center MDRC   (Canada)

^d UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

adipokines; body composition; energy expenditure; inflammation; insulin sensitivity; lipid profile

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; CLAMP; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; EQUIPMENT; FEMALE; HUMAN; HYPERINSULINEMIA; INFORMATION; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; MUSCLE STRENGTH; MUSCLE TRAINING; OBESITY; OXYGEN CONSUMPTION; POSTMENOPAUSE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; RISK FACTOR; TRAINING; AGED; BLOOD; CANADA; HEART MUSCLE; METABOLISM; MIDDLE AGED;

ADIPONECTIN; AGED; CANADA; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR WEIGHT; MYOCARDIUM; OBESITY; POSTMENOPAUSE; RISK FACTORS; ROC CURVE;

EID: 77954224041     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1253404     Document Type: Article

References (28)

1. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. End Rev 2005 26 439-451
2. Whitehead J, Richards A, Hickman I, Macdonald GA, Prins JP. Adiponectin a key adipokine in the metabolic syndrome. Diab Ob Met 2006 8 264-280
3. Koebnick C, Roberts CK, Shaibi GQ, Kelly LA, Lane CJ, Toledo-Corral CM, Davis JN, Ventura EE, Alexander K, Weigensberg MJ, Goran MI. Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta-cell function in overweight Hispanic adolescents. Horm Metab Res 2008 40 708-712
4. Krentz AJ, von Mühlen D, Barrett-Connor E. Adipocytokines, sex hormones, and cardiovascular risk factors in postmenopausal women: factor analysis of the Rancho Bernado study. Horm Metab Res 2009 41 773-777
5. Kadowaki T, Yamaushi T, Kubota N Kazuo H, Kohjiro U, Kazuyuki T. Adiponectin and adiponectin receptors in insulin resitance, diabetes, and the metabolic syndrome. J Clin Inv 2006 116 1784-1792
6. Weiss M, Orvos J, Flyvbjerg A, Miserez AR, Frytsyk J, Sinnreich R, Kark JD. Adiponectin and lipoprotein particle size. Diabetes Care 2009 32 1317-1319
7. Lindsay R, Funahashi T, Hanson R, Matsuzawa Y, Tanaka S, Tataranni A, Knowler W, Krakof J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002 360 57-58
8. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004 279 12152-12162
9. Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP, Hwang JJ, Yang WS. The clinical implications of blood adiponectin in cardio-metabolic disorders. J Formos Med Assoc 2009 108 353-366
10. Lu JY, Huang KC, Chang LC, Huang YS, Chi YC, Su TC, Chen CL, Yang WS. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci 2008 15 565-576
11. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 2003 278 307-316
12. Guerre-Millo M. Adiponectin: An update. Diabetes Metab 2008 34 12-18
13. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008 149 W307-W366
14. von Eynatten M, Lepper PM, Humpert PM. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise program: comparative evaluation of three assays: response to Bluher etal. Diabetes Care 2007 30 e67
15. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006 55 249-259
16. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular-weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 1357-1362
17. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF, Patsch JR. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008 38 827-834
18. Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 2007 30 280-285 (Pubitemid 46198331)
19. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S, Kuroda Y, Hayashi N, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Funahashi T, Matsuzawa Y. Osaka CAD Group. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J 2008 72 23-28 (Pubitemid 351413321)
20. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin Levels and Risk of Type 2 Diabetes. A Systematic Review and Meta-analysis. JAMA 2009 302 179-188
21. Jürimäe J, Jürimäe T, Ring-Dimitriou S, LeMura LM, Arciero PJ, von Duvillard SP. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women. Metabolism 2009 58 638-643
22. Brochu M, Malita MF, Messier V, Doucet E, Strychar I, Lavoie JM, Prudhomme D, Rabasa-Lhoret R. Resistance training does not contribute to improve the metabolic profile after a 6-month weight loss program in overweight and obese postmenopausal women. J Clin Endocrinol Metab 2009 94 3226-3233
23. Strychar I, Lavoie ME, Messier L, Karelis AD, Doucet E, Prudhomme D, Fontaine J, Rabasa-Lhoret R. Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: A MONET (Montreal Ottawa New Emerging Team) study. Journal of the American Dietetic Association 2009 109 718-724
24. Karelis AD, Fontaine J, Messier V, Messier L, Blanchard C, Rabasa-Lhoret R, Strychar I. Psychosocial correlates of cardiorespiratory fitness and muscle strength in overweight and obese post-menopausal women: a MONET study. J Sports Sci 2008 26 935-940
25. Brochu M, Mathieu ME, Karelis AD, Doucet E, Lavoie ME, Garrel D, Rabasa-Lhoret R. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: A MONET study. Obesity 2008 16 1085-1093
26. Messier V, Malita FM, Rabasa-Lhoret R, Brochu M, Karelis AD. Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study. Metabolism 2008 57 1293-1298
27. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983 148 839-843
28. Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, Federspil G, Sechi LA, Vettor R. Plasma adiponectin is decreased in non-alcoholic fatty liver disease. Eur J Endocrinol 2009 152 113-118